The benefit of upgrading chronically right ventricle–paced heart failure patients to resynchronization therapy demonstrated by strain rate imaging

BACKGROUND

RV pacing induces conduction delay (CD), mechanical dyssynchrony, and increased morbidity in patients with HF. CRT improves HF symptoms and survival, but sparse data exist on its direct effect on chronically RV-paced HF patients.

OBJECTIVES

To assess the benefit of cardiac resynchronization therapy (CRT) in chronically right ventricle (RV)-paced heart failure (HF) patients.

METHODS

We studied 12 consecutive patients with class III HF who had a previously implanted pacemaker or implantable cardioverter-defibrillator. These individuals were chronically RV paced and referred for upgrade to a biventricular device by their primary cardiologists. Tissue Doppler and strain rate imaging (TDI and SRI, respectively) were performed immediately before each upgrade and 4-6 weeks afterward to quantify changes in regional wall motion and synchrony with CRT.

RESULTS

CRT significantly reduced the mean QRS duration (205 ms to 156 ms; P<.0001), and it increased the ejection fraction (30.7%+/-5.1% to 35.8%+/-5.1%; P<.01). Left ventricular end-systolic and end-diastolic dimensions were also significantly reduced. Clinically, patients improved by an average of one New York Heart Association (NYHA) functional class after upgrade (P = .006). The parameter exhibiting greatest improvement was the coefficient of variation (CoV: standard deviation/mean) of time to peak systolic strain rate, a marker of ventricular dyssynchrony, which decreased from 34.3%+/-13.0% to 19.0%+/-6.6% (P<.01). Reduction in CoV of time to peak systolic strain rate was maximally seen in the midventricle (38.2%+/-19.6% to 16.5%+/-9.7%; P<.01).

CONCLUSIONS

Upgrading chronically RV-paced HF patients to CRT improves global and regional systolic function. TDI and SRI provide compelling evidence that this benefit parallels that seen in HF patients with CD unrelated to RV pacing, which implies that biventricular pacing synchronizes mechanical activation in different myocardial regions in patients upgraded from RV pacing as well.

Echocardiography and patient selection for cardiac resynchronization therapy: A critical appraisal

Echocardiography has been the focus of growing interest for improving patient selection for cardiac resynchronization therapy in order to reduce the number of nonresponders. Various techniques have been described for assessing dyssynchrony, using standard echocardiography (pulsed-wave Doppler and M-mode echocardiography), tissue Doppler imaging, and other imaging modes such as three-dimensional echocardiography. This article provides an overview of the technical and practical aspects of these different techniques and discusses the current evidence for optimizing patient selection by echocardiography.

[Comparison of coronary angiography findings in diabetic and non-diabetic women with non-ST-segment-elevation acute coronary syndrome]

OBJECTIVE

Compare hemodynamic and angiographic patterns, as well as atherosclerotic lesion morphology, in diabetic and non-diabetic females with unstable angina or non-ST-segment-elevation myocardial infarction (UA/NSTEMI).

METHODS

Two interventional cardiologists determined the presence of severe atherosclerotic lesion, defined as those > or = 70%; plaque morphology, according to the American Heart Association classification; collateral circulation; plus ventricular and aortic pressures. Ejection fraction was calculated by angiography or echocardiography.

RESULTS

During eight and a half years, 645 coronary angiographies were performed in women with UA/NSTEMI. In the present study, 593 female patients were assessed (215 diabetic--36%). This group differed from the non-diabetic in the following aspects: older age (61 +/- 10.6 x 58.1 +/- 11.4), higher prevalence of postmenopausal women and lower prevalence of the smoking habit. Severe three-vessel disease was significantly more frequent in diabetic patients (28% x 10%), as well as totally occluded vessels: 51 (23%) x 54 (14.3%), p < 0.005. Additionally, ejection fraction < 50% was more common in diabetic patients.

CONCLUSION

These findings confirm the diffuse pattern of atherosclerotic disease in diabetic patients, as well a greater deterioration of ventricular function, which may be associated to the poorer prognosis seen in this population both in the short- and long-term.

Timing on 16-slice scanner and implications for 64-slice cardiac CT: do you start scanning immediately after breath hold?

RATIONALE AND OBJECTIVES

Slow heart rate and small changes in heart rate are factors for improving image quality on spiral cardiac computed tomography (CT). The purpose of this study is to investigate whether it is possible to improve non-enhanced cardiac CT quality by delaying the data-acquisition window after breath hold.

MATERIALS AND METHODS

Electrocardiograph files (n = 240) for 16-slice non-enhanced cardiac CT scans were analyzed. Mean heart rates and maximal changes in heart rates between adjacent cardiac cycles were compared between phase 1 (defined as cardiac cycles 1-5), phase 2 (cardiac cycles 2-6), ... , and phase 6 (cardiac cycles 6-10).

RESULTS

Heart rates gradually increased by phases, but were limited to a range of 66.8-68.0 beats/min. Maximal changes in heart rates were 2.5 beats/min (phase 1) at the highest and 1.3 beats/min (phases 5 and 6) at the lowest (t-test; P < .01). Maximal changes in heart rates for more than five beats/min occurred in 24, eight, and eight patients on phases 1, 5, and 6, respectively (chi-square test; P < .01).

CONCLUSION

The delayed scan (four or five cardiac cycles after breath hold) has the potential to improve the quality of non-enhanced cardiac CT.

Intra-operative Volume Imaging of the Left Atrium and Pulmonary Veins with Rotational X-Ray Angiography

Complex electrophysiology (EP) procedures, such as catheter-based ablation in the left atrium and pulmonary veins (LAPV) for treatment of atrial fibrillation, require knowledge of heart chamber anatomy. Electroanatomical mapping (EAM) is typically used to define cardiac structures by combining electromagnetic spatial catheter localization with surface models which interpolate the anatomy between EAM point locations in 3D. Recently, the incorporation of pre-operative volumetric CT or MR data sets has allowed for more detailed maps of LAPV anatomy to be used intra-operatively. Preoperative data sets are however a rough guide since they can be acquired several days to weeks prior to EP intervention. Due to positional and physiological changes, the intra-operative cardiac anatomy can be different from that depicted in the pre-operative data. We present a novel application of contrast-enhanced rotational X-ray imaging for CT-like reconstruction of 3D LAPV anatomy during the intervention itself. We perform two selective contrast-enhanced rotational acquisitions and reconstruct CT-like volumes with 3D filtered back projection. Two volumes depicting the left and right portions of the LAPV are registered and fused. The combined data sets are then visualized and segmented intra-procedurally to provide anatomical data and surface models for intervention guidance. Our results from animal and human experiments indicate that the anatomical information from intra-operative CT-like reconstructions compares favorably with pre-acquired CT data and can be of sufficient quality for intra-operative guidance.

Reproducible microvascular dysfunction with dobutamine infusion in Takotsubo cardiomyopathy presenting with ST segment elevation

Takotsubo (ampulla) cardiomyopathy, or broken heart syndrome, is an underrecognized cardiac illness that usually presents as an acute coronary syndrome in postmenopausal females. The disorder is frequently associated with episodes of mental or physical stress, implicating an abnormal cardiac response to increased catecholamines. Although death has been reported during the index event, the long-term prognosis is good with full recovery of left ventricular function. We present a case of Takotsubo cardiomyopathy mimicking anterior ST segment elevation myocardial infarction precipitated by dobutamine stress testing. Reinfusion of dobutamine in the catheterization laboratory reproduced symptoms with angiography and intravascular ultrasound supporting the theory of abnormal microvascular circulation as the etiology of Takotsubo cardiomyopathy. Acute and delayed magnetic resonance imaging demonstrated no infarction with complete recovery of ventricular function.

Surgical Closure of the Left Atrial Appendage – A Beneficial Procedure?

BACKGROUND

Closure of the fibrillating left atrial appendage (LAA) has been recommended during valve surgery to decrease the risk of arterial embolism. However, patients undergoing surgical LAA closure have not systematically been reevaluated for complete LAA obliteration.

METHODS AND RESULTS

During a 12-month period, we studied 6 consecutive patients with paroxysmal (n = 3) or permanent (n = 3) atrial fibrillation who underwent surgical LAA closure at the time of valve surgery. Transesophageal echocardiography (TEE) performed 23-159 days (mean 51) postoperatively demonstrated complete LAA closure in only 1 patient. In 5 patients, incomplete LAA closure was found due to disruption of the closure line. The size of the residual LAA orifice ranged from 3 to 20 mm. There was a high flow velocity at the LAA orifice (0.33-2.2 m/s), whereas flow in the LAA body was low (<0.2 m/s). Spontaneous echocardiographic contrast (SEC) in the LAA had newly developed (n = 3) or was much more intense than preoperatively (n = 2). Despite therapeutic anticoagulation 2 patients showed a LAA thrombus which had not been present on the preoperative TEE, and 1 patient with SEC suffered a stroke 4 weeks after attempted LAA closure.

CONCLUSION

Surgical LAA closure was incomplete in most patients, resulting in blood stagnation and an increased likelihood of clot formation. Incomplete surgical LAA closure, therefore, may promote rather than reduce the risk of stroke. Intraoperative TEE is mandatory to verify complete LAA obliteration.

The severity of myocardial ischemia can be predicted by the exercise electrocardiogram

The aim of the study was to evaluate the utility of exercise-induced ECG changes in predicting the degree of myocardial ischemia as compared to angiographic and nuclear scintigraphic images. Four hundred and seventy one patients in whom exercise nuclear scintigraphy and coronary angiography revealed significant coronary narrowing (> or =70% luminal diameter narrowing) were studied. Down-sloping ST depression was found to be the best predictor of a large area of reversible ischemia (RI). Time of resolution of ST depression was the second most powerful predictor and the time of onset of ST depression was the third best predictor. RI on nuclear scintigraphy correlated better than angiographic findings with the ECG changes.

Identification of good responders to rhythm control of paroxysmal and persistent atrial fibrillation by transthoracic and transesophageal echocardiography

BACKGROUND

Identification of good responders to rhythm control in the management of atrial fibrillation (AF) is worthwhile in terms of increasing hemodynamic benefit and decreasing the likelihood of unstable anticoagulation even after the Atrial Fibrillation Follow-Up Investigation of Rhythm Management.

METHODS

We tested the hypothesis that atrial substrate determines the risk of recurrence on rhythm control both in patients with paroxysmal AF (PAF) and in those with persistent or sustained AF (> or =1 week, SAF). There were 90 consecutive patients (mean age 63 +/- 12 years, 67 males and 23 females) with previous PAF (n = 66) or SAF (n = 24). They were maintained in sinus rhythm successfully for at least 1 month after conversion and then studied by transthoracic and transesophageal echocardiography. All of the patients were followed regularly by determination of symptoms, 12-lead ECG and intermittent Holter recording to determine recurrence of AF after echocardiographic study.

RESULTS

After 9.1 +/- 3.8 (range 3-12) months of follow-up, 23 of the 90 (26%) patients had documented recurrence of AF (67 without recurrence). Univariate analysis of demographic characteristics, medications, ECG and echocardiographic parameters revealed that, compared with the group of patients without recurrent AF, the group of those with it included more members of the SAF group (11/27 vs. 13/67, p = 0.039), included more male subjects (22/23 vs. 45/67, p = 0.045), had a larger left atrial volume index (LAVI; 27 +/- 9 vs. 22 +/- 9 ml/m2, p = 0.024) and had lower LA appendage peak emptying velocity (LAAPEV; 42 +/- 15 vs. 55 +/- 22 cm/s, p = 0.01). Multivariate Cox proportional hazards regression analysis adjusted for age, gender and AF group revealed that patients with LAVI <30 ml/m2 and LAAPEV >46 cm/s had the least recurrence of AF (relative risk 0.18, 95% confidence interval 0.06-0.55, vs. with LAVI >30 ml/m2 or LAAPEV <46 cm/s, p = 0.002). Kaplan-Meier probability of freedom from AF recurrence was significantly better when LAVI <30 ml/m2 (log-rank p = 0.02), LAAPEV > 46 cm/s (p = 0.013) or both (p = 0.004). The superiority to predict the rate of sinus rhythm maintenance was the same in the PAF and SAF groups.

CONCLUSIONS

Good responders to rhythm control in the PAF and SAF groups share the characteristics of smaller LA volume and better LAA contractile function, emphasizing the critical role of atrial substrate remodeling in recurrence of AF.

Effect of left atrial circumferential ablation for atrial fibrillation on left atrial transport function

BACKGROUND

The effects of left atrial (LA) circumferential ablation on LA function in patients with atrial fibrillation (AF) have not been well described.

OBJECTIVES

The purpose of this study was to determine the effect of LA circumferential ablation on LA function.

METHODS

Gated, multiphase, dynamic contrast-enhanced computed tomographic (CT) scans of the chest with three-dimensional reconstructions of the heart were used to calculate the LA ejection fraction (EF) in 36 patients with paroxysmal (n = 27) or chronic (n = 9) AF (mean age 55 +/- 11 years) and in 10 control subjects with no history of AF. Because CT scans had to be acquired during sinus rhythm, a CT scan was available both before and after (mean 5 +/- 1 months) LA circumferential ablation (LACA) in only 10 patients. A single CT scan was acquired in 8 patients before and in 18 patients after LACA ablation. Radiofrequency catheter ablation was performed using an 8-mm-tip catheter to encircle the pulmonary veins, with additional lines along the mitral isthmus and the roof.

RESULTS

In patients with paroxysmal AF, LA EF was lower after than before LACA (21% +/- 8% vs 32 +/- 13%, P = .003). LA EF after LA catheter ablation was similar among patients with paroxysmal AF and those with chronic AF (21% +/- 8% vs 23 +/- 13%, P = .7). However, LA EF after LA catheter ablation was lower in all patients with AF than in control subjects (21% +/- 10% vs 47% +/- 5%, P < .001).

CONCLUSION

During medium-term follow-up, restoration of sinus rhythm by LACA results in partial return of LA function in patients with chronic AF. However, in patients with paroxysmal AF, LA catheter ablation results in decreased LA function. Whether the impairment in LA function is severe enough to predispose to LA thrombi despite elimination of AF remains to be determined.

Sympathetic Nerve Activity After Thoracoscopic Cardiac Resynchronization Therapy in Congestive Heart Failure

BACKGROUND

Sympathetic benefits of thoracoscopic cardiac resynchronization therapy (TCRT) in congestive heart failure (CHF) are unknown. We determined cardiac hemodynamics, functional status, and muscle sympathetic nerve activity (MSNA) in a group of TCRT patients. We aimed to compare these patients with CHF patients with cardiac asynchrony (ASY) to substantiate the beneficial effects of TCRT.

METHODS AND RESULTS

Eleven patients resynchronized by TCRT 6 +/- 1 months before study inclusion (SYN) and 10 matched ASY patients underwent blood pressure, heart rate, and MSNA recordings. All underwent functional status, cardiac index, and left ventricular ejection fraction (LVEF) assessments. SYN patients had shorter QRS duration and interventricular mechanical delays, longer 6 minute walking distance and lower New York Heart Association class (all P < .05) than ASY patients. MSNA of 56 +/- 2 bursts/min in ASY patients was higher than in SYN patients (48 +/- 3 bursts/min, P < .05). Cardiac index was higher in SYN patients than in ASY patients (2.8 +/- 0.2 versus 1.9 +/- 0.2 L.min.m2, P < .05, respectively). MSNA was highest in the patients with the lowest LVEF (r = -0.49, P < .05), cardiac index (r = -0.48, P < .05) and 6-minute walking distance (r = -0.50, P < .05).

CONCLUSION

Lower sympathetic nerve activities in TCRT patients are related to more favorable cardiac indexes and six minute walking distances suggesting a sympathetic, hemodynamic, and functional improvement by TCRT.

Ischemic ventricular arrhythmias during heart failure: A canine model to replicate clinical events

BACKGROUND

Development of experimental animal models has played an invaluable role in understanding the mechanisms of ventricular arrhythmias.

OBJECTIVES

The purpose of this study was to evaluate a new canine model of myocardial infarction (MI), heart failure, and ischemic ventricular arrhythmias in an attempt to replicate clinical conditions.

METHODS

Thirty-six mongrel dogs underwent placement of a permanent ventricular pacemaker and induction of an anterior MI by percutaneous transcatheter embolization of polyvinyl foam particles into the left anterior descending coronary artery (just distal to the first septal branch). After a 2-week recovery period, heart failure was induced by continuous rapid ventricular pacing at 200 to 240 ppm for 3 weeks. Transient (4-minute) myocardial ischemia was induced via balloon occlusion of the proximal left circumflex coronary artery. Echocardiographic and electrophysiologic testing was performed before MI creation and repeated prior to acute ischemia induction.

RESULTS

Seven dogs (19%) died within several hours of MI creation. All surviving dogs developed severe left ventricular systolic dysfunction. Significant increases in the intraatrial and intraventricular conduction intervals were observed following MI creation and heart failure induction compared with baseline values, as evidenced by increases in the duration of the P wave and QRS complex. Significant increases in corrected QT interval and ventricular refractoriness were observed. Acute transient ischemia induced sustained ventricular tachycardia or ventricular fibrillation in 21 of 29 dogs (72%).

CONCLUSION

This canine model can serve as a useful tool for studying ventricular arrhythmias during the interactions of healed infarction, heart failure, increased sympathetic tone, and myocardial ischemia.

Noninvasive three-dimensional electrocardiographic imaging of ventricular activation sequence

Imaging the myocardial activation sequence is critical for improved diagnosis and treatment of life-threatening cardiac arrhythmias. It is desirable to reveal the underlying cardiac electrical activity throughout the three-dimensional (3-D) myocardium (rather than just the endocardial or epicardial surface) from noninvasive body surface potential measurements. A new 3-D electrocardiographic imaging technique (3-DEIT) based on the boundary element method (BEM) and multiobjective nonlinear optimization has been applied to reconstruct the cardiac activation sequences from body surface potential maps. Ultrafast computerized tomography scanning was performed for subsequent construction of the torso and heart models. Experimental studies were then conducted, during left and right ventricular pacing, in which noninvasive assessment of ventricular activation sequence by means of 3-DEIT was performed simultaneously with 3-D intracardiac mapping (up to 200 intramural sites) using specially designed plunge-needle electrodes in closed-chest rabbits. Estimated activation sequences from 3-DEIT were in good agreement with those constructed from simultaneously recorded intracardiac electrograms in the same animals. Averaged over 100 paced beats (from a total of 10 pacing sites), total activation times were comparable (53.3 +/- 8.1 vs. 49.8 +/- 5.2 ms), the localization error of site of initiation of activation was 5.73 +/- 1.77 mm, and the relative error between the estimated and measured activation sequences was 0.32 +/- 0.06. The present experimental results demonstrate that the 3-D paced ventricular activation sequence can be reconstructed by using noninvasive multisite body surface electrocardiographic measurements and imaging of heart-torso geometry. This new 3-D electrocardiographic imaging modality has the potential to guide catheter-based ablative interventions for the treatment of life-threatening cardiac arrhythmias.

Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history

OBJECTIVES

The aim of this study was to investigate the clinical expression of adenosine monophosphate-activated protein kinase (AMPK) gene mutations (PRKAG2) in adenosine monophosphate (AMP) kinase disease based on 12 years follow-up of known mutation carriers and to define the prevalence of PRKAG2 mutations in hypertrophic cardiomyopathy (HCM).

BACKGROUND

Adenosine monophosphate-activated protein kinase gene mutations cause HCM with Wolff-Parkinson-White syndrome and conduction disease.

METHODS

Clinical evaluation of 44 patients with known AMP kinase disease was analyzed. Mutation analysis of PRKAG2 was performed by fluorescent single-strand confirmation polymorphism analysis and direct sequencing of abnormal conformers in 200 patients with HCM.

RESULTS

Only one additional mutation was identified. The mean age at clinical diagnosis in the 45 gene carriers was 24 years (median 20 years, range 9 to 55 years). Symptoms of palpitation, dypspnea, chest pain, or syncope were present in 31 (69%) gene carriers; 7 (15%) complained of myalgia and had clinical evidence of proximal myopathy. Skeletal muscle biopsy showed excess mitochondria and ragged red fibers with minimal glycogen accumulation. Disease penetrance defined by typical electrocardiogram abnormalities was 100% by age 18 years. Thirty-two of 41 adults (78%) had left ventricular hypertrophy (LVH) on echocardiography, and progressive LVH was documented during follow-up. Survival was 91% at a mean follow-up of 12.2 years. Progressive conduction disease required pacemaker implantation in 17 of 45 (38%) at a mean age of 38 years.

CONCLUSIONS

The AMP kinase disease is uncommon in HCM and is characterized by progressive conduction disease and cardiac hypertrophy and includes extracardiac manifestations such as a skeletal myopathy, consistent with a systemic metabolic storage disease. Defects in adenosine triphosphate utilization or in specific cellular substrates, rather than mere passive deposition of amylopectin, may account for these clinical features.

Combined Effects of Nifekalant and Lidocaine on the Spiral-Type Re-Entry in a Perfused 2-Dimensional Layer of Rabbit Ventricular Myocardium

BACKGROUND

Spiral re-entry plays the principal role in the genesis of ventricular tachycardia and ventricular fibrillation (VT/VF). The specific I(Kr) blocker, nifekakant (NIF) has, often in combination with lidocaine (LID), recently been used in Japan to prevent recurrent VT/VF, but the combined effects of these drugs on spiral re-entry had never been investigated.

METHODS AND RESULTS

A ventricular epicardial sheet was obtained from 13 Langendorff-perfused rabbit hearts by means of a cryoprocedure, and epicardial excitations were analyzed with a high-resolution optical mapping system. Nifekakant (0.5 micromol/L) caused significant prolongation of action potential duration (APD) and LID (3 micromol/L) attenuated the APD prolongation without affecting the conduction velocity. VT were induced in 6 hearts by cross-field stimulation, and single- or double-loop spirals circulating around variable functional block lines were visualized during the VT. Nifekakant reduced VT cycle length and caused early termination in association with destabilization of the spiral dynamics (prolongation of functional block line, frequent local conduction block, and extensive meandering). These modifications of spiral-type re-entrant VT by NIF were prevented by addition of LID.

CONCLUSIONS

The effects of NIF on the spiral excitations are reversed by LID. This interaction should be taken into account when these drugs are used in combination to treat VT/VF.

Safety and Feasibility of Cryothermal Ablation Within the Mid‐ and Distal Coronary Sinus

INTRODUCTION

The aim of this study was to assess the safety and feasibility of catheter-based cryothermal ablation lesions in the mid- and distal coronary sinus.

METHODS AND RESULTS

Cryothermal ablation lesions were delivered using a 7-French catheter at the mid- (n = 13) and distal (n = 12) coronary sinus in 14 swine under general anesthesia. Lesions were delivered for 2 or 4 minutes in a 1:2 randomized ratio such that seven 2-minute lesions and eighteen 4-minute lesions were delivered to a maximum negative temperature of -70 degrees C. Integrity of the circumflex artery was assessed by angiography before and after each lesion application. In five animals, arterial Doppler flow velocity was continuously monitored and coronary flow reserve assessed. Histologic assessment of the left AV ring was made after a 48-hour survival period and lesions graded for depth and transmurality. Eighteen of 25 lesions were >3 mm deep: five of seven 2-minute lesions and thirteen of eighteen 4-minute lesions. Lesions were transmural in 18 of 25 cases. Two transmural lesions were limited in depth due to their epicardial position. One 2-minute mid-coronary sinus lesion was not found. Adherent thrombus was seen grossly in the coronary sinus at one site and only on microscopic examination in three other lesions. Angiography demonstrated no arterial spasm or thrombosis. Continuous-flow Doppler remained unchanged throughout lesion production. Coronary flow reserve was unchanged (1.7 +/- 0.8 preablation vs 1.7 +/- 1.0 postablation, P = 0.6). The media and intima were preserved in all cases. Necrosis of the adventitia was seen in one arterial segment.

CONCLUSION

Catheter-based cryoablation can produce lesions in the musculature of the adjacent atrium and ventricle when accessed from the coronary sinus without significant injury to the coronary sinus or adjacent artery. This method has potential application as the ablation method of choice when such lesions are required.

Wall thickening assessment with tissue harmonic echocardiography results in improved risk stratification for patients with non-ST-segment elevation acute chest pain

OBJECTIVES

To demonstrate whether the improved imaging quality gained by using tissue harmonic echocardiography in place of fundamental echocardiography results in the improved risk stratification of patients presenting with non-ST-elevation acute chest pain.

METHODS AND RESULTS

Eighty patients with over 30 min of non-ST-elevation chest pain that had lasted less than 6 h were recruited. All patients underwent resting tissue harmonic and fundamental echocardiographic scans. Diagnosis for acute myocardial infarction was made on a 24 h creatine kinase-MB sample. Echocardiographic images were reported by two experienced blinded observers. Patients were followed up at least 4 months after admission. Endpoints included all-cause mortality, non-fatal myocardial infarction and revascularisation procedures. Tissue harmonic echocardiography allowed assessment of all myocardial segments in all patients compared to 43/78 patients ( p<0.001 ) with fundamental echocardiography. A wall thickening abnormality demonstrated on tissue harmonic echocardiography and not fundamental echocardiography was a significant predictor of index myocardial infarction on admission ( p<0.007 ) and for an adverse cardiac event during follow up ( p=0.002 ).

CONCLUSIONS

Tissue harmonic echocardiography is superior to fundamental echocardiography for accurate assessment of systolic wall thickening and hence risk stratification for patients presenting with acute chest pain and non-diagnostic electrocardiogram changes.

Transmembraneous irrigation of multipolar radiofrequency ablation catheters: induction of linear lesions encircling the pulmonary vein ostium without the risk of coagulum formation?

INTRODUCTION

Pulmonary vein (PV) isolation for the curative treatment of atrial fibrillation using conventional radiofrequency ablation (RF) catheters with the point by point technique is time consuming and carries a remaining risk for thrombembolic complications.

AIMS OF THE STUDY

Aim of the present in vivo study was to evaluate feasibility and safety of a novel multipolar irrigated ablation catheter designed to create contiguous lesions encircling the PV ostium in a single ablation position.

METHODS

The entire ablation section (tripolar, length of each electrode 22 mm, interelectrode distance 2 mm, helix radius: 9 and 10 mm) of the 7F RF catheter (Encirclr, Medtronic, MN, USA) was covered by a porous membrane (pore size 30 micron) providing continuous irrigation. The helical formed catheter was used in two different experimental settings. Initially, a thigh muscle preparation has been performed in 7 anesthetized sheep in order to evaluate the development of lesions at different power level (40-80 W) and RF duration (30-90 sec). The ablation catheter was placed at the surface of the thigh muscle in a perpendicular position (0.1 N contact pressure) and perfused with heparinized blood (250 ml/min, 37C degrees ). Irrigation was provided with a flow rate of 10 ml/min. The resulted lesion morphology was evaluated with regard to coagulum or crater formation and lesion depth and diameter. Subsequently in 9 anesthetized sheep intracardiac ablation has been achieved with 50 W and an irrigation flow of 10 ml/min. Transseptal puncture and RF ablations were guided using fluoroscopy and intracardiac echocardiography (ICE, Acuson, USA). Endpoint of the intracardiac RF applications was the reduction of local electrogram amplitude >50%. RF applications were achieved at both atrial appendages and in the orifices of the coronary sinus (CS), the vena cava inferior (VCI) and PV. Following RF ablation all animals were sacrificed and following in vivo staining (2% TTC) macroscopically and histologically investigations of the lesions were performed.

RESULTS

At the thigh muscle preparation 57 RF applications have been performed. The lesion depth was homogeneous without gaps between the ablation electrodes. There was a significant increase comparing 30 with 90 sec of RF duration for 40, 50 and 60 W applications respectively: 40 W: 1.1 +/- 0.4 vs. 3.6 +/- 0.5; 50 W: 1.2 +/- 0.3 vs. 4.6 +/- 0.4 mm and 60 W: 2.6 +/- 0.6 vs. 4.8 +/- 0.5 mm. All applications with 80 W (n = 3) had to be terminated due to immediate increase of impedance >150 omega. Late impedance rises (>60 sec) without occurrence of coagulum formation have been observed in 1 out of 4 RF applications with 60 W.A total of 85 RF applications could be achieved intracardiacally in the right atrium (right atrial appendage n = 18, ostium of the coronary sinus n = 12, ostium of the inferior caval vein: n = 12) and in the left atrium (left atrial appendage: n = 15, ostium of the PV: n = 28). ICE guided positioning of the catheter and showed during all applications no coagulum formation at the electrode or impedance rise (>150 Omega). Reduction of local electrograms (>50%) were observed following 48 out 85 (56%) RF applications. The lesions showed a homogeneous depth of 4 +/- 2 mm and a width 5 +/- 2 mm at the surface. No charring or crater formation could be observed in any of the lesions.

CONCLUSIONS

In the present in vivo studies it could be demonstrated that long irrigated ablation electrodes induce continuous lesions without the risk of thrombus formation at the electrode. Increase of RF duration from 30 to 90 seconds with power setting of 40-60 W, respectively, created deeper lesions without the risk of thrombus formation. Thus, the helical formed irrigated ablation catheter appears to be appropriate for simplified PV isolation.

Pulmonary vein isolation by microwave energy ablation in patients with permanent atrial fibrillation

BACKGROUND

Atrial fibrillation is associated with significant morbidity and mortality. Microwave energy ablation (MW) is a new option for surgical treatment of permanent atrial fibrillation (pAF). We present our experience with surgical treatment of mitral valve disease (MVD), coronary artery disease (CAD), and aortic valve disease (AVD) and microwave ablation in patients with pAF.

METHODS

In 202 consecutive patients (100 female, 102 male, age 68.3 +/- 8.1 years from 30.4 to 83.5 years, ejection fraction 25-80%, left atrial diameter 56 +/- 9.1 mm from 30 to 102 mm) with an indication for a cardiosurgical intervention, pAF was documented for 6.8 +/- 9.1 years. MW was performed using two different lesion concepts. In the first 140 patients we used an ablation line starting at the posterior mitral valve annulus and incorporated the interior of all pulmonary veins. After the first 137 patients we switched to a different ablation line concept. Starting at the posterior mitral valve the annulus ablation line additionally included the left atrial appendix. Another ablation circle around the pulmonary veins of both sides was created and both circles were connected. If opening of the right atrium was necessary additional isthmus ablation was performed.

RESULTS

Survival rate was 98.5%. There were no ablation-related complications. In the 6-month follow-up 87 patients were in sinus rhythm (65%), in the 1-year follow-up 74 patients were in SR (62.2%).

CONCLUSIONS

Microwave ablation is a safe and efficient method for surgical treatment of pAF in patients with a concomitant cardiosurgical procedure. The short duration for this additional procedure and easy application has made this procedure the method of choice in our institution for treatment of pAF in patients with cardiosurgical operations.

Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy

INTRODUCTION

Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) has major implications for the management of patients and their first-degree relatives. Diagnosis is based on a set of criteria proposed by the International Task Force for Cardiomyopathies. We report our experience in providing a re-evaluation for patients who previously have been diagnosed with ARVD/C.

METHODS AND RESULTS

We studied 89 patients who requested a re-evaluation for diagnosis of ARVD/C at our center. Each of these patients had been diagnosed with ARVD/C at their initial evaluation. Each patient was re-evaluated with clinical history, physical examination, and noninvasive testing at our center. Invasive testing, which included electrophysiologic testing, right ventricular angiography, and endomyocardial biopsy, was performed when clinically indicated. Sixty (92%) of the 65 patients who had undergone magnetic resonance imaging (MRI) at an outside institution were reported to have an abnormal MRI consistent with ARVD/C. Among these patients, the only abnormality identified was the qualitative finding of intramyocardial fat/wall thinning in 46 patients. On re-evaluation, these qualitative findings were not confirmed. None of these 46 patients ultimately were diagnosed with ARVD/C. Among the entire patient group, only 24 (27%) of the 89 patients met the Task Force criteria for ARVD/C.

CONCLUSION

This study demonstrates that the high frequency of "misdiagnosis" of ARVD/C is due to over-reliance on the presence of intramyocardial fat/wall thinning on MRI, incomplete diagnostic testing, and lack of awareness of the Task Force criteria. Diagnosis of ARVD/C cannot rely solely upon qualitative features on MRI.

Intracardiac echocardiography to guide transseptal catheterization for radiofrequency catheter ablation of left-sided accessory pathways: two case reports

Intracardiac echocardiography (ICE) is a useful tool for guiding transseptal puncture during electrophysiological mapping and ablation procedures. Left-sided accessory pathways (LSAP) can be ablated by using two different modalities: retrograde approach through the aortic valve and transseptal approach with puncture of the fossa ovalis. We shall report two cases of LSAP where transcatheter radiofrequency ablation (TCRFA) was firstly attempted via transaortic approach with ineffective results. Subsequently, a transseptal approach under ICE guidance has been performed. During atrial septal puncture ICE was able to locate the needle tip position precisely and provided a clear visualization of the "tenting effect" on the fossa ovalis. ICE allowed a better mapping of the mitral ring and a more effective catheter ablation manipulation and tip contact which resulted in a persistent and complete ablation of the accessory pathway with a shorter time of fluoroscopic exposure. ICE-guided transseptal approach might be a promising modality for TCRFA of LSAP.

Acute angiographic analysis of non-ST-segment elevation acute myocardial infarction

Most revascularization studies on acute myocardial infarction have included patients who have ST-segment elevation or new-onset left bundle branch block. However, the characteristics of patients who have non-ST-segment elevation acute myocardial infarction and who have undergone angiographic analysis of their infarct-related arteries have not been adequately described. This study suggests that these patients are likely to have had coronary bypass surgery (odds ratio 4.58, 95% confidence interval 1.83 to 11.5, p = 0.0012) and that circumflex artery occlusions are more likely to present as non-ST-segment elevation than as acute myocardial infarction with ST-segment elevation and/or left bundle branch block (odds ratio 2.91, 95% confidence interval 1.62 to 5.22, p = 0.0003).